Granulocytes in coronary thrombus evolution after myocardial infarction - Time-dependent changes in expression of matrix metalloproteinases

Cardiovascular Pathology

Volumn 25, Issue 1, 2016, Pages 40-46

  Li, Xiaofei ^a   De Boer, Onno J ^a   Ploegmaker, Hanneke ^a   Teeling, Peter ^a   Daemen, Mat Jap ^a   De Winter, Robbert J ^a   Van Der Wal, Allard C ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Acute myocardial infarction; Atherosclerosis; Coronary artery; Granulocytes; Immunohistochemistry; Inflammation; Matrix metalloproteinase; Thrombosis

Indexed keywords

GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; NEUTROPHIL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ACUTE HEART INFARCTION; ARTICLE; ATHEROSCLEROTIC PLAQUE; BALLOON DILATATION; BLOOD CLOTTING; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY THROMBOSIS; CYTOLYSIS; GENE EXPRESSION; GRANULOCYTE; HEALING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; NEUTROPHIL; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBECTOMY; BIOPSY; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; CORONARY THROMBOSIS; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MYOCARDIAL INFARCTION; PATHOLOGY; TIME FACTOR;

BIOPSY; CORONARY ARTERY DISEASE; CORONARY THROMBOSIS; CORONARY VESSELS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GRANULOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASES; MYOCARDIAL INFARCTION; PLAQUE, ATHEROSCLEROTIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THROMBECTOMY; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 84951794807     PISSN: 10548807     EISSN: 18791336     Source Type: Journal    
DOI: 10.1016/j.carpath.2015.09.007     Document Type: Article

References (36)

1. MJ Davies, and AC Thomas Plaque fissuring - the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina Br Heart J 53 1985 363 373
2. AC van der Wal, and AE Becker Atherosclerotic plaque rupture - pathologic basis of plaque stability and instability Cardiovasc Res 41 1999 334 344
3. E Falk Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi Br Heart J 50 1983 127 134
4. J Mann, and MJ Davies Mechanisms of progression in native coronary artery disease: role of healed plaque disruption Heart 82 1999 265 268
5. AP Burke, FD Kolodgie, A Farb, DK Weber, GT Malcom, J Smialek, and et al. Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression Circulation 103 2001 934 940
6. R Henriques de Gouveia, AC van der Wal, CM van der Loos, and AE Becker Sudden unexpected death in young adults. Discrepancies between initiation of acute plaque complications and the onset of acute coronary death Eur Heart J 23 2002 1433 1440
7. SZ Rittersma, AC van der Wal, KT Koch, JJ Piek, JP Henriques, KJ Mulder, and et al. Plaque instability frequently occurs days or weeks before occlusive coronary thrombosis: a pathological thrombectomy study in primary percutaneous coronary intervention Circulation 111 2005 1160 1165
8. MC Kramer, AC van der Wal, KT Koch, JP Ploegmakers, RJ van der Schaaf, JP Henriques, and et al. Presence of older thrombus is an independent predictor of long-term mortality in patients with ST-elevation myocardial infarction treated with thrombus aspiration during primary percutaneous coronary intervention Circulation 118 2008 1810 1816
9. MY Flugelman, R Virmani, R Correa, ZX Yu, A Farb, MB Leon, and et al. Smooth muscle cell abundance and fibroblast growth factors in coronary lesions of patients with nonfatal unstable angina. A clue to the mechanism of transformation from the stable to the unstable clinical state Circulation 88 1993 2493 2500
10. TW Wakefield, RM Strieter, CA Wilke, AM Kadell, SK Wrobleski, MD Burdick, and et al. Venous thrombosis-associated inflammation and attenuation with neutralizing antibodies to cytokines and adhesion molecules Arterioscler Thromb Vasc Biol 15 1995 258 268
11. LJ Downing, RM Strieter, AM Kadell, CA Wilke, JC Austin, BD Hare, and et al. IL-10 regulates thrombus-induced vein wall inflammation and thrombosis J Immunol 161 1998 1471 1476
12. G Sawicki, E Salas, J Murat, H Miszta-Lane, and MW Radomski Release of gelatinase A during platelet activation mediates aggregation Nature 386 1997 616 619
13. SW Galt, S Lindemann, L Allen, DJ Medd, JM Falk, TM McIntyre, and et al. Outside-in signals delivered by matrix metalloproteinase-1 regulate platelet function Circ Res 90 2002 1093 1099
14. C Johnson, and ZS Galis Matrix metalloproteinase-2 and -9 differentially regulate smooth muscle cell migration and cell-mediated collagen organization Arterioscler Thromb Vasc Biol 24 2004 54 60
15. AC Newby Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates Cardiovasc Res 69 2006 614 624
16. BC Nwomeh, HX Liang, IK Cohen, and DR Yager MMP-8 is the predominant collagenase in healing wounds and nonhealing ulcers J Surg Res 81 1999 189 195
17. FG Kushner, M Hand, SC Smith, SB King, JL Anderson, EM Antman, and et al. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 120 2009 2271 2306
18. S Rozen, and H Skaletsky Primer3 on the WWW for general users and for biologist programmers Methods Mol Biol 132 2000 365 386
19. CM van der Loos Multiple immunoenzyme staining: methods and visualizations for the observation with spectral imaging J Histochem Cytochem 56 2008 313 328
20. B Price, C Dennison, H Tschesche, and E Elliott Neutrophil tissue inhibitor of matrix metalloproteinases-1 occurs in novel vesicles that do not fuse with the phagosome J Biol Chem 275 2000 28308 28315
21. AC Newby Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture Physiol Rev 85 2005 1 31
22. RP Iyer, NL Patterson, GB Fields, and ML Lindsey The history of matrix metalloproteinases: milestones, myths, and misperceptions Am J Physiol Heart Circ Physiol 303 2012 H919 H930
23. C Adlbrecht, D Bonderman, C Plass, J Jakowitsch, G Beran, W Sperker, and et al. Active endothelin is an important vasoconstrictor in acute coronary thrombi Thromb Haemost 97 2007 642 649
24. DS Rao, JG Goldin, and MC Fishbein Determinants of plaque instability in atherosclerotic vascular disease Cardiovasc Pathol 14 2005 285 293
25. K Inkinen, H Turakainen, H Wolff, L Ravanti, VM Kahari, and J Ahonen Expression and activity of matrix metalloproteinase-2 and -9 in experimental granulation tissue APMIS 108 2000 318 328
26. BC Nwomeh, HX Liang, RF Diegelmann, IK Cohen, and DR Yager Dynamics of the matrix metalloproteinases MMP-1 and MMP-8 in acute open human dermal wounds Wound Repair Regen 6 1998 127 134
27. YB Zhang, W Li, LQ Yao, XL Zhao, B Wang, HK Li, and et al. Expression changes and roles of matrix metalloproteinases in a rat model of traumatic deep vein thrombosis Chin J Traumatol 13 2010 188 192
28. SJ Weiss, G Peppin, X Ortiz, C Ragsdale, and ST Test Oxidative autoactivation of latent collagenase by human neutrophils Science 227 1985 747 749
29. S Chakrabarti, and KD Patel Regulation of matrix metalloproteinase-9 release from IL-8-stimulated human neutrophils J Leukoc Biol 78 2005 279 288
30. M Faurschou, and N Borregaard Neutrophil granules and secretory vesicles in inflammation Microbes Infect 5 2003 1317 1327
31. M Muller, C Trocme, B Lardy, F Morel, S Halimi, and PY Benhamou Matrix metalloproteinases and diabetic foot ulcers: the ratio of MMP-1 to TIMP-1 is a predictor of wound healing Diabet Med 25 2008 419 426
32. EI Deryugina, B Ratnikov, E Monosov, TI Postnova, R DiScipio, JW Smith, and et al. MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells Exp Cell Res 263 2001 209 223
33. GS Butler, MJ Butler, SJ Atkinson, H Will, T Tamura, S Schade van Westrum, and et al. The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study J Biol Chem 273 1998 871 880
34. KJ Leco, P Waterhouse, OH Sanchez, KL Gowing, AR Poole, A Wakeham, and et al. Spontaneous air space enlargement in the lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3) J Clin Invest 108 2001 817 829
35. DS Smookler, FF Mohammed, Z Kassiri, GS Duncan, TW Mak, and R Khokha Tissue inhibitor of metalloproteinase 3 regulates TNF-dependent systemic inflammation J Immunol 176 2006 721 725
36. S Lenglet, A Thomas, P Chaurand, K Galan, F Mach, and F Montecucco Molecular imaging of matrix metalloproteinases in atherosclerotic plaques Thromb Haemost 107 2012 409 416